Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placental extract injection for ovarian rejuvenation in premature ovarian failure
IRCT20191123045476N7Phase 3Recruiting
- Sponsor
- Iran University of Medical Sciences
- Start
- Oct 2026
- Modality
- Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, double-blind, single-arm trial of LAENNEC in ovarian hypofunction (POI), sponsored by Iran University of Medical Sciences. Primary endpoints: Change in AMH level, Change in FSH level and 1 more. Started Oct 2026; status: recruiting.
02
Drugs
LAENNEC
03
Conditions
ovarian hypofunction (POI)
Beyond the preview
Go deeper on IRCT20191123045476N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191123045476N7.